Status:

RECRUITING

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study

Lead Sponsor:

Wake Forest University Health Sciences

Conditions:

Cardiac Amyloidosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Exercise training in patients with heart failure and preserved ejection fraction (HFpEF) has been associated with an improvement in cardiorespiratory fitness and quality of life.

Detailed Description

The Atrium Health cardiac rehabilitation program delivers a comprehensive approach to improve cardiac performance including supervised exercise programs and has the ideal infrastructure to offer cardi...

Eligibility Criteria

Inclusion

  • Age \> 18
  • New York Heart Association (NYHA) Class I-III Heart Failure
  • Able to Exercise
  • On stable treatment for their cardiac amyloidosis or under active surveillance
  • Life expectancy of at least 6 months
  • Ability to understand and the willingness to sign a written informed consent document in English, and the willingness/ability to comply with the protocol activities
  • Participant must be able and willing to follow the cardiac rehabilitation activities

Exclusion

  • Inability to provide informed consent
  • Inability to commit to in-person supervised exercise sessions for three one-hour sessions a week for 12 weeks
  • NYHA Class IV Heart Failure
  • Pulmonary disease requiring home oxygen
  • Gait instability or history of prior falls
  • In the opinion of the Principal Investigator, have a clinically significant comorbid disease that is likely to affect the ability of the patient to complete the trial, interfere with their ability with measurement of self-reported outcomes.

Key Trial Info

Start Date :

January 22 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2027

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06096675

Start Date

January 22 2024

End Date

June 1 2027

Last Update

July 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sanger Heart and Vascular Institute

Charlotte, North Carolina, United States, 28204

CAPACITY (Cardiac Amyloidosis and Physical ACtivITY) Study | DecenTrialz